Perampanel Patent Expiration
Perampanel is used for controlling seizures in patients with epilepsy. It was first introduced by Catalyst Pharmaceuticals Inc
Perampanel Patents
Given below is the list of patents protecting Perampanel, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fycompa | US8772497 | Method for producing 1, 2-dihydropyridine-2-one compound | Jul 01, 2026 | Catalyst Pharms |
| Fycompa | US6949571 | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
May 23, 2025
(Expired) | Catalyst Pharms |
Perampanel's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List